Wendell David Associates’s CONMED CNMD Stock Holding History

Wendell David Associates’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,625	Closed	-$210K	–	161
2024 Q1	$210K	Hold	2,625	–	–	0.02%	158
2023 Q4	$287K	Hold	2,625	–	–	0.03%	143
2023 Q3	$265K	Hold	2,625	–	–	0.03%	140
2023 Q2	$357K	Hold	2,625	–	–	0.04%	122
2023 Q1	$273K	Hold	2,625	–	–	0.03%	131
2022 Q4	$233K	Hold	2,625	–	–	0.03%	136
2022 Q3	$210K	Hold	2,625	–	–	0.03%	140
2022 Q2	$251K	Hold	2,625	–	–	0.03%	137
2022 Q1	$390K	Hold	2,625	–	–	0.04%	122
2021 Q4	$372K	Hold	2,625	–	–	0.04%	126
2021 Q3	$343K	Hold	2,625	–	–	0.04%	129
2021 Q2	$361K	Hold	2,625	–	–	0.04%	127
2021 Q1	$343K	Hold	2,625	–	–	0.04%	126
2020 Q4	$294K	Hold	2,625	–	–	0.04%	126
2020 Q3	$207K	Buy	+2,625	New	+$214K	0.03%	140
2020 Q1	–	Sell	-2,625	Closed	-$294K	–	141
2019 Q4	$294K	Hold	2,625	–	–	0.04%	138
2019 Q3	$252K	Hold	2,625	–	–	0.04%	141
2019 Q2	$225K	Hold	2,625	–	–	0.03%	147
2019 Q1	$218K	Buy	+2,625	New	+$191K	0.03%	149
2018 Q4	–	Sell	-2,625	Closed	-$208K	–	144
2018 Q3	$208K	Buy	+2,625	New	+$203K	0.03%	153

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Wendell David Associates's CNMD Position: Q2 2024 in Review

Wendell David Associates sold out of CONMED (CNMD) in Q2 2024, closing a stake of 2,625 shares — an estimated $210K sold.

Wendell David Associates first reported a position in CNMD in Q3 2018 and held it in 20 quarters. The position peaked at $390K in Q1 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

Wendell David Associates reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
Wendell David Associates sold 2,625 CONMED shares in Q2 2024, an estimated $210K.
Wendell David Associates first reported a position in CONMED in Q3 2018 and held it in 20 quarters.
Wendell David Associates's CONMED position peaked at $390K in Q1 2022.
290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Wendell David Associates's 13F filing for Q2 2024, filed 22 Jul 2024.